155 related articles for article (PubMed ID: 35695657)
21. Noncovalent liposome linkage and miniaturization of capsosomes for drug delivery.
Hosta-Rigau L; Chandrawati R; Saveriades E; Odermatt PD; Postma A; Ercole F; Breheney K; Wark KL; Städler B; Caruso F
Biomacromolecules; 2010 Dec; 11(12):3548-55. PubMed ID: 21090570
[TBL] [Abstract][Full Text] [Related]
22. Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core.
Okamoto Y; Taguchi K; Yamasaki K; Sakuragi M; Kuroda S; Otagiri M
J Pharm Sci; 2018 Jan; 107(1):436-445. PubMed ID: 28826882
[TBL] [Abstract][Full Text] [Related]
23. ATB
Luo Q; Yang B; Tao W; Li J; Kou L; Lian H; Che X; He Z; Sun J
Biomater Sci; 2017 Jan; 5(2):295-304. PubMed ID: 27991616
[TBL] [Abstract][Full Text] [Related]
24. Coencapsulation of arsenic- and platinum-based drugs for targeted cancer treatment.
Chen H; Pazicni S; Krett NL; Ahn RW; Penner-Hahn JE; Rosen ST; O'Halloran TV
Angew Chem Int Ed Engl; 2009; 48(49):9295-9. PubMed ID: 19894238
[No Abstract] [Full Text] [Related]
25. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide.
Lin C; Zhang X; Chen H; Bian Z; Zhang G; Riaz MK; Tyagi D; Lin G; Zhang Y; Wang J; Lu A; Yang Z
Drug Deliv; 2018 Nov; 25(1):256-266. PubMed ID: 29334814
[TBL] [Abstract][Full Text] [Related]
26. Enhanced anticancer therapy mediated by specialized liposomes.
Dass CR; Walker TL; Burton MA; Decruz EE
J Pharm Pharmacol; 1997 Oct; 49(10):972-5. PubMed ID: 9364404
[TBL] [Abstract][Full Text] [Related]
27. The suitability of liposomes for the delivery of hydrophobic drugs - A case study with curcumin.
Kolter M; Wittmann M; Köll-Weber M; Süss R
Eur J Pharm Biopharm; 2019 Jul; 140():20-28. PubMed ID: 31015019
[TBL] [Abstract][Full Text] [Related]
28. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
29. Tumor targeting using liposomal antineoplastic drugs.
Huwyler J; Drewe J; Krähenbuhl S
Int J Nanomedicine; 2008; 3(1):21-9. PubMed ID: 18488413
[TBL] [Abstract][Full Text] [Related]
30. Inhaled chemotherapy in lung cancer: future concept of nanomedicine.
Zarogoulidis P; Chatzaki E; Porpodis K; Domvri K; Hohenforst-Schmidt W; Goldberg EP; Karamanos N; Zarogoulidis K
Int J Nanomedicine; 2012; 7():1551-72. PubMed ID: 22619512
[TBL] [Abstract][Full Text] [Related]
31. Nanohybrid magnetic liposome functionalized with hyaluronic acid for enhanced cellular uptake and near-infrared-triggered drug release.
Nguyen VD; Zheng S; Han J; Le VH; Park JO; Park S
Colloids Surf B Biointerfaces; 2017 Jun; 154():104-114. PubMed ID: 28329728
[TBL] [Abstract][Full Text] [Related]
32. Liposomes for Antibiotic Encapsulation and Delivery.
Gonzalez Gomez A; Hosseinidoust Z
ACS Infect Dis; 2020 May; 6(5):896-908. PubMed ID: 32208673
[TBL] [Abstract][Full Text] [Related]
33. A novel tumor-targeted thermosensitive liposomal cerasome used for thermally controlled drug release.
Li S; Yin G; Pu X; Huang Z; Liao X; Chen X
Int J Pharm; 2019 Oct; 570():118660. PubMed ID: 31491484
[TBL] [Abstract][Full Text] [Related]
34. Recent Patents, Formulation Techniques, Classification and Characterization of Liposomes.
Sheoran R; Khokra SL; Chawla V; Dureja H
Recent Pat Nanotechnol; 2019; 13(1):17-27. PubMed ID: 30479223
[TBL] [Abstract][Full Text] [Related]
35. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery.
Eloy JO; Claro de Souza M; Petrilli R; Barcellos JP; Lee RJ; Marchetti JM
Colloids Surf B Biointerfaces; 2014 Nov; 123():345-63. PubMed ID: 25280609
[TBL] [Abstract][Full Text] [Related]
36. Improved Therapeutic Efficacy of Topotecan Against A549 Lung Cancer Cells with Folate-targeted Topotecan Liposomes.
Zhang J; Shi W; Xue G; Ma Q; Cui H; Zhang L
Curr Drug Metab; 2020; 21(11):902-909. PubMed ID: 32851958
[TBL] [Abstract][Full Text] [Related]
37. Carbonic anhydrase IX-directed immunoliposomes for targeted drug delivery to human lung cancer cells in vitro.
Wong BC; Zhang H; Qin L; Chen H; Fang C; Lu A; Yang Z
Drug Des Devel Ther; 2014; 8():993-1001. PubMed ID: 25092965
[TBL] [Abstract][Full Text] [Related]
38. Targeted liposomal drug delivery: a nanoscience and biophysical perspective.
Liu Y; Castro Bravo KM; Liu J
Nanoscale Horiz; 2021 Feb; 6(2):78-94. PubMed ID: 33400747
[TBL] [Abstract][Full Text] [Related]
39. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
Alavi M; Hamidi M
Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
[TBL] [Abstract][Full Text] [Related]
40. Lipid-based drug delivery systems for cancer treatment.
Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
